Classification of primary tumors of the central nervous system: A historical remembrance

Authors

Carlos E. Velásquez, Departmento de Neurocirug´ıa, Centro Medico Nacional 20 de Noviembre del ISSSTE en la Ciudad de M ´ exico
Diego Méndez-Rosito, Departmento de Neurocirugía, Centro Medico Nacional 20 de Noviembre del ISSSTE en la Ciudad de MéxicoFollow

Document Type

Original Article

Abstract

Tumors of the central nervous system constitute a heterogeneous group of neoplasms that range from well-differentiated and relatively benign lesions to highly invasive and poorly differentiated lesions. In the pursuit of unifying criteria to establish therapeutic options and clarify prognosis, classification systems for this group of neoplasms have emerged, which initially relied on their macroscopic characteristics and more recently have incorporated genetic studies. This constantly evolving classification brings greater accuracy in the diagnosis of neoplasms but poses new challenges for its implementation and gives rise to new questions, new study techniques, and new classification methods, understanding that what is modern today will be history tomorrow.

Recommended Citation

Velásquez, Carlos E. and Méndez-Rosito, Diego (2024) "Classification of primary tumors of the central nervous system: A historical remembrance," LATIN Neurosurgery Journal: Vol. 1: Iss. 2, Article 8.
Available at: https://www.latin-neurosurgery.org/home/vol1/iss2/8

References

[1] American Cancer Society, Inc. All rights reserved. site online, 2019. 2019 American Cancer Society, Inc. All rights reserved. Site online.

[2] Paula de Robles, Kirsten M Fiest, Alexandra D Frolkis, Tamara Pringsheim, Callie Atta, Christine St. Germaine-Smith, Lundy Day, Darren Lam, and Nathalie Jette. The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis. Neuro-oncology, 17(6):776– 783, 2015.

[3] David N Louis. Who classification of tumours of the central nervous system. (No Title), 2016.

[4] Nils RingeTtz. Grading of gliomas, 1949. August 12th, 1949, from the neurosurgical clinic of the Serafimerlasarett.

[5] Symposium on a new and simplified concept of gliomas. In Proceedings of the Staff Meetings of the Mayo Clinic, volume 24, page 54, 1949.

[6] Julio Escalona Zapata. La ultima clasifi- ´ cacion de la o.m.s. de los tumores del sistema ´ nervioso (2000), consideraciones acerca de los oligodendrogliomas. Revista Espanola de Pa- ˜ tolog´ıa, 2000.

[7] Michael Noel Hart, Carol K Petito, and Kenneth M Earle. Mixed gliomas. Cancer, 33(1):134–140, 1974.

[8] Martin C Raff, Robert H Miller, and Mark Noble. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature, 303(5916):390–396, 1983.

[9] Martin C Raff, Erika R Abney, and Robert H Miller. Two glial cell lineages diverge prenatally in rat optic nerve. Developmental biology, 106(1):53–60, 1984.

[10] David N. Louis, Hiroko Ohgaki, and Webster K. Cavenee. WHO Classification of Tumours of the Central Nervous System. World Health Organization, Geneva, Switzerland, 2016.

[11] David N. Louis, Hiroko Ohgaki, Otmar D. Wiestler, and Webster K. Cavenee. World Health Organization Histological Classification of Tumours of the Central Nervous System. International Agency for Research on Cancer, Lyon, 2007.

[12] David N Louis. The next step in brain tumor classification:“let us now praise famous men”. . . or molecules? Acta neuropathologica, 124(6):761–762, 2012.

[13] David N. Louis, Hiroko Ohgaki, Otmar D. Wiestler, and Webster K. Cavenee. World Health Organization Histological Classification of Tumours of the Central Nervous System. International Agency for Research on Cancer, France, 2016.

[14] Mariana Sinning. Clasificacion de los tumores ´ cerebrales, brain tumor classification. Revista Medica Cl ´ ´ınica Las Condes, 2017.

[15] David N Louis, Arie Perry, Peter Burger, David W Ellison, Guido Reifenberger, Andreas von Deimling, Kenneth Aldape, Daniel Brat, V Peter Collins, Charles Eberhart, et al. International society of neuropathology-haarlem consensus g uidelines for nervous s ystem tumor classification and grading. Brain pathology, 24(5):429–435, 2014.

[16] David N Louis. Who classification of tumours of the central nervous system. (No Title), 2016.

[17] C Giannini, BW Scheithauer, AL Weaver, PC Burger, JM Kros, S Mork, MB Graeber, S Bauserman, JC Buckner, J Burton, et al. Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading. Journal of Neuropathology & Experimental Neurology, 60(3):248–262, 2001.

[18] Martin J Van Den Bent. Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective. Acta neuropathologica, 120(3):297–304, 2010.

[19] Cancer Genome Atlas Research Network. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. New England Journal of Medicine, 372(26):2481–2498, 2015.

[20] Felix Sahm, David Reuss, Christian Koelsche, David Capper, Jens Schittenhelm, Stephanie Heim, David TW Jones, Stefan M Pfister, Christel Herold-Mende, Wolfgang Wick, et al. Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma. Acta neuropathologica, 128:551–559, 2014.

[21] Benedikt Wiestler, David Capper, Martin Sill, David TW Jones, Volker Hovestadt, Dominik Sturm, Christian Koelsche, Anna Bertoni, Leonille Schweizer, Andrey Korshunov, et al. Integrated dna methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma. Acta neuropathologica, 128:561–571, 2014.

[22] Derek R. Johnson et al. 2016 updates to the who brain tumor classification system: What the radiologist needs to know. RadioGraphics, 37(7):2164–2180, 2016.

[23] David N Louis, Arie Perry, Peter Burger, David W Ellison, Guido Reifenberger, Andreas von Deimling, Kenneth Aldape, Daniel Brat, V Peter Collins, Charles Eberhart, et al. I nternational s ociety of n europathology-h aarlem c onsensus g uidelines for n ervous s ystem t umor c lassification and g rading. Brain pathology, 24(5):429–435, 2014.